Navigation Links
Gleevec for Lung Disease

Pulmonary fibrosis is a progressive lung disease that, according to the Pulmonary Fibrosis Foundation, claims the lives of 40,000 people every year. There's often not a known cause although// smoking and some occupations are risk factors. Now, a new treatment may give patients what they're looking for -- more time.

Michael Dixon is enjoying every minute he has with his wife Debbie. Earlier this year, his doctor told him he had a lung disease called pulmonary fibrosis. "He gave me, at most, a 50/50 chance of making five years, and that's when it sunk in," Michael tells Ivanhoe.

He only has half of his lung capacity right now, but as time passes, it will decrease even more. He says, "The hardest part was telling my kids that I might not be around."

Michael is determined to stay around, so he enrolled in a study at Tulane University Health Sciences Center with Pulmonologist Joseph Lasky, M.D..

"The idea of the use of Gleevec is to stop the disease from getting worse once the patient has been diagnosed," Dr. Lasky tells Ivanhoe.

Gleevec has received national attention for its success in treating leukemia. Because fibrosis and cancer share some of the mechanisms of the development of the disease, Dr. Lasky says doctors thought it might be of some benefit for the patients who have fibrosis.

In this disease, scars form on the lungs. Those scars soon take over, and the lungs stop working. Based on lab studies, Dr. Lasky says Gleevec should stop that scarring.

"At best, we hope to stop the progression of the disease," he says. "It's our hope that the treatment of Gleevec will increase the length of their life as well as improve the quality."

The research is currently ongoing to find out just how effective Gleevec is.

For the study, Michael takes six pills a day and hopes they'll give him and his lungs a little more time. "I'd say 99 percent of the time, I believe it's going to
'"/>




Page: 1 2

Related medicine news :

1. Gleevec gets hopeful results
2. "Miracle" Cancer Drug Gleevec Can be Toxic to the Heart
3. Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors
4. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
5. Vitamins-The answer to Heart Disease?
6. Link between Constipation and Parkinsons Disease
7. Levels Of Blood Proteins May Help Heart Disease Care
8. New Drug PP188 Helps Sickle Cell Disease
9. Gene Treatment for Heart Disease
10. Legume Consumption Can Cut Heart Disease Risk
11. Link Between Infection And Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gleevec for Lung Disease

(Date:7/8/2008)...WASHINGTON, July 8, 2008) The American Society of...al recipients of its Alternative Training Pathway ...ctors to encourage the development and implementat... , Thomas Abshire, MD, of Emory University, Don..., and David Sternberg, MD, PhD, of Mount Sinai Sch...
(Date:7/8/2008)...is new executive team will give the men we serve a...aid Carl J. Bentley, President, M.I. Board of ...y 8 /PRNewswire/ -- The Mariners Inn shelter and t...the appointment of Jim Hartz as,chief executive of...., "Both Jim and David are outstanding leaders in...
(Date:7/8/2008)...ecently identified genetic markers, called single ...ed with a small but statistically significant incr... substantially improve the accuracy of existing mo...idual,s risk, according to a study in the July 8 o... Institute . , Risk prediction models provide es...
(Date:7/8/2008)...Will Not Reduce Competition and Will Help to Lower...engthen the Pennsylvania Economy, PITTSBURGH, Jul...rk and,Independence Blue Cross (IBC) testified her...ment public hearing about the combination of,the t...omers, health care,providers, and the communities ...
Breaking Medicine News(10 mins):Health News:Mariners Inn Announces New Executive Leadership 2Health News:Single-nucleotide polymorphisms do not substantially improve risk prediction for breast cancer 2Health News:Highmark and Independence Blue Cross CEOs Say Combination of Highmark and Independence Blue Cross will Provide $1 Billion in New Resources Over Six Years 2
...ts of fake medicines, most of them from India, wer...// , according to officials here. The fake medici...t cancer and high cholesterol and condoms. A sampl...what was being passed off as a cardiovascular drug...
...e developed a new method that advocates the use of...s// . D. Karunagaran, a professor at the departme...hnology (IIT) in Madras, and Suby Oommen, a PhD st...iotechnology in Kerala, have been working on garli...
...ed that there are crucial differences in brain che...cts stress and emotions.// The study adds further...c alterations within the brain -- specifically in ...a central part of the brain's natural pain and str...
...ity of Michigan Medical School have uncovered the ...renal failure //in children, which is because of m...or PLCE1. Discovering the mutant gene is crucial ...e development of podocytes – that are unique cells...
Other Medicine News:Health News:Garlic compound may help treat cancer 2Health News:Women in the throes of depression portray differences in brain chemistry 2Health News:Women in the throes of depression portray differences in brain chemistry 3Health News:Chronic Kidney Disease Related To Mutant Gene 2Health News:Chronic Kidney Disease Related To Mutant Gene 3Health News:Chronic Kidney Disease Related To Mutant Gene 4
(Date:7/8/2008)... NEW YORK, July 8 /- McGraw-Hill...ation resources for the scientific and medical,com... new drug,effectiveness reference to its comprehen...rmacy (http://www.accesspharmacy.com ). Through a...ributed databases generated from clinical,studies,...
(Date:7/8/2008)... - Focalin XR demonstrated better symptom contr...post-dose in primary and secondary endpoints,- Onl...30 minutes post-dose, - Additional analysis sugges... Concerta over 12 hours - Sym...(ADHD) can,significantly impact a child,s ability ...
(Date:7/7/2008)... - Dimebon Significantly Improves Cognition a...ton,s Disease Patients - - Findings Warrant Fur...- Conference Call Scheduled for Today at 5:00 p.m....ll/ -- Medivation, Inc.,(Nasdaq: MDVN ) today ann...,that its investigational drug Dimebon(TM) signifi...
(Date:7/7/2008)... NEW YORK, July 7 /- P...s announced that its subsidiary, PulmoScience,Inc.... DFH-12 product,candidate for the PulmoBind techno...f the lungs., Molecular Imaging uses a molecule d...he body. In the case of PulmoBind, the chosen mole...
Breaking Medicine Technology:McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy 2Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 2Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 3Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 4Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 5Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 6Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 7Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 8Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 2Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 4Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 5Pulmo BioTech Inc. Completes Bio-Distribution Studies 2Pulmo BioTech Inc. Completes Bio-Distribution Studies 3Surgical Care Affiliates and UCSD Medical Center to Partner in Surgical Center 8806 1Surgical Care Affiliates and UCSD Medical Center to Partner in Surgical Center 8806 2Fewer Children Outgrowing Allergies to Milk Eggs 8804 1Fewer Children Outgrowing Allergies to Milk Eggs 8804 2Brief intervention helps emergency patients reduce drinking 8802 1Brief intervention helps emergency patients reduce drinking 8802 2Brief intervention helps emergency patients reduce drinking 8802 3U S Census Bureau Daily Feature for December 26 8800 1
...LAMEDA, Calif.--(BUSINESS WIRE)--Jun 21, 2007 - Ad...cessfully produced a human,embryonic stem cell (hE...n Worcester, Massachusetts. This development was a...nd Scientific Development of,Advanced Cell Technol...f the International Society for Stem Cell Research...
...IAMI--(BUSINESS WIRE)--Jun 21, 2007 - Answerthink,...ormed a strategic alliance with,LORENZ Life Scienc...in North America. Answerthink and LORENZ Life Scie...ting best practice submissions,management solution...on SAP technology., Answerthink,s pre-configured E...
Other Medicine Technology:Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 2Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 3Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry 2Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry 3
Used following open gallbladder procedure to drain bile. Often attached to Bard bile bag.
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe.
Bard® Channel Drain
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte
Medicine Products: